Taste-Masking
Advanced technology conceals bitterness of APIs.
Our Taste Mask Granules are designed to address one of the biggest challenges in oral drug delivery – the bitter or unpleasant taste of many active pharmaceutical ingredients (APIs). By masking bitterness while preserving therapeutic efficacy, we create patient-friendly formulations that improve acceptance and adherence across all age groups. We utilize specialized coating, complexation, and microencapsulation technologies to develop safe, stable, and high-performance granules. These formulations are widely used in oral suspensions, dispersible tablets, chewable tablets, and pediatric or geriatric medicines, where taste plays a vital role in compliance.





Our Taste Mask Granules are specially engineered to improve the palatability of bitter APIs without affecting their bioavailability or therapeutic activity. By combining innovative polymer coatings with advanced drug layering techniques, we ensure that the active ingredient remains masked during ingestion but is readily released at the absorption site.
We apply multiple taste-masking approaches including polymer coating, ion-exchange resin complexation, and microencapsulation depending on the nature of the API and the target formulation. This ensures a flexible approach that can be adapted for different dosage forms such as oral liquids, dispersible tablets, dry syrups, and chewables.
Our facilities adhere to EU,SFDA,WHO GMP standards, ensuring that every batch of Taste Mask Granules is uniform, safe, and pharmaceutically robust. With expertise in customized development, we help global pharma companies create differentiated, patient-centric formulations that stand out in competitive markets.

Advanced technology conceals bitterness of APIs.

Supports concentrated formulations without compromising taste-masking

Ensures consistent mixing, dosage accuracy, formulation performance.

Excellent flow properties enable seamless manufacturing & processing.

Enhances compliance, particularly for pediatric and geriatric populations.

Suitable for oral suspensions, chewables, dispersible tablet & other dosage forms.
| Product Name | Percentage Available | Therapeutic Usage |
|---|---|---|
| Azithromycin | 7.5% | Anti-bacterial |
| Ciprofloxacin | 20% / 40% | Anti-bacterial |
| Clarithromycin | 27.5% / 42% / 43% | Anti-bacterial |
You will get End-to-end complete information about our product

Advanced formulations tailored to market needs.

International regulatory compliance

Flexible batch sizes and strength variations

Dedicated support and transparent processes

Trusted pharmaceutical partner across multiple geographies